Diabetes Metab J.
2021 Sep;45(5):795-795. 10.4093/dmj.2021.0256.
Time in Range from Continuous Glucose Monitoring: A Novel Metric for Glycemic Control
- Affiliations
-
- 1Division of Endocrinology and Metabolism, Department of Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea
- 2Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
- KMID: 2520864
- DOI: http://doi.org/10.4093/dmj.2021.0256
Figure
-
Fig. 1. (A) Even in patients with the same glycosylated hemoglobin (HbA1c) or mean glucose, exact glycemic control may vary. For example, some patients can have excellent glycemic control, spending the whole day with glucose levels between 70 and 180 mg/dL; on the other hand, some patients’ glucose levels may range from 50 to 250 mg/dL. (B) Self-monitoring blood glucose (SMBG) cannot fully capture actual glycemic fluctuation like continuous glucose monitoring (CGM) measuring interstitial glucose level every 5 to 15 minutes (96 to 288 measurements/day). TAR, time above range; TBR, time below range; TIR, time in range.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Time in Range from Continuous Glucose Monitoring: A Novel Metric for Glycemic Control
- Application of Continuous Glucose Monitoring System (CGMS) and Patient Education
- Importance of continuous glucose monitoring in the treatment of diabetes mellitus
- Use of Flash Glucose Monitoring in Patients on Intensive Insulin Treatment
- Advances in Glucose Monitoring and Insulin Therapy in Intensive Care Unit Patients
